| Q34957285 | Analgesic tone conferred by constitutively active mu opioid receptors in mice lacking β-arrestin 2 |
| Q37252077 | Caged naloxone reveals opioid signaling deactivation kinetics |
| Q39359627 | Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons |
| Q38250226 | Endogenous analgesia, dependence, and latent pain sensitization |
| Q58798205 | Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity |
| Q56889524 | Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor |
| Q44349884 | Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord |
| Q38998329 | Opioids and Chronic Pain: Where Is the Balance? |
| Q36505623 | Regulation and Functional Implications of Opioid Receptor Splicing in Opioid Pharmacology and HIV Pathogenesis |
| Q36591603 | Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. |
| Q50596818 | Reply to Wang and Sadée. |
| Q36431999 | Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive Activity |
| Q42090559 | The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours |